Engineered enzyme erases a stubborn mark of aging by up to 70% in human tissue samples

Researchers have developed an engineered enzyme capable of erasing a specific, stubborn mark of aging within human tissue samples. According to reports from Phys.org and Nature, the process involves enzymatic deglycation to reverse protein chemical aging. The enzyme targets protein damage that chemists describe as being similar to the way bread turns brown in a toaster, a condition that builds up in human tissue over several decades. In tests using donor skin, the enzyme succeeded in reversing more than half of this damage, with Phys.org specifically noting a reversal rate of up to 70% in the samples tested. Coverage of this breakthrough is appearing across a range of scientific and mainstream outlets. Business Wire reports that Revel Pharmaceuticals and their collaborators are the entities reporting this enzymatic reversal.

Technical details are highlighted by C&EN, which describes how enzyme engineers are tackling this specific form of protein damage. The-scientist.com employs a metaphor to describe the process, characterizing the engineered enzyme as acting like a lawnmower to rewind decades of molecular aging. The Miami Herald focuses on the potential consumer implications, questioning if the technology could eventually eliminate wrinkles. To understand the significance of this development, it is necessary to recognize the nature of the protein damage being addressed. The coverage identifies this as a chemical hallmark of aging that persists and accumulates over a long period. This process of glycation creates a stubborn mark that has historically been difficult to erase.

By utilizing an engineered enzyme for deglycation, the researchers are attempting to undo molecular changes that typically signify the aging process in human biological tissues, specifically in the donor skin samples utilized for this research. Future developments will depend on the continued findings from Revel Pharmaceuticals and their collaborators. Observers will be looking for whether the success seen in human tissue samples can be translated into broader applications. While the Miami Herald raises the possibility of treating wrinkles, the current factual record is limited to the enzymatic reversal of chemical aging in donor skin and human tissue samples. Further reports will likely specify whether this deglycation process can be applied in living organisms or if it remains limited to the laboratory samples cited by Nature and other scientific publications.